Please login to the form below

Not currently logged in
Email:
Password:

Zykadia

This page shows the latest Zykadia news and features for those working in and with pharma, biotech and healthcare.

Pfizer claims rapid FDA nod for Lorbrena

Pfizer claims rapid FDA nod for Lorbrena

Xalkori has, however, seen sales dwindle due to competition from newer drugs such as Novartis’ Zykadia and Takeda’s Alunbrig. ... Lorbrena can also be used in patients who have seen disease progression on Roche’s Alecensa and Novartis’ Zykadia.

Latest news

More from news
Approximately 12 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • Pharma deals during October 2014 Pharma deals during October 2014

    The phase 1/2 studies will assess Novartis' Zykadia [ceritinib], INC 280 and EGF 816 in combination with BMS's PD-1 immune checkpoint inhibitor nivolumab [Opdivo]. ... Zykadia is approved in the US for patients with anaplastic lymphoma kinase (ALK) and

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics